Date | Time | Source | Headline | Symbol | Company |
06/26/2024 | 2:09PM | iHub Newswire | FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program | | |
06/26/2024 | 5:34PM | PR Newswire (US) | LANDMARK ADMIN LLC PROVIDES NOTICE OF DATA PRIVACY EVENT | | |
06/26/2024 | 5:31PM | PR Newswire (US) | Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular Therapies, Palvella Therapeutics | | |
06/26/2024 | 5:31PM | PR Newswire (US) | Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular Therapies, Palvella Therapeutics | | |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM | EU:SAN | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM | TG:SNW | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans | TG:SNW | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM | EU:SAN | Sanofi |
06/26/2024 | 5:30PM | Business Wire | National Beverage Corp. Reports Record Fourth Quarter and Fiscal Year-end Results...Corporate Endorphins at Work | NASDAQ:FIZZ | National Beverage Corporation |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Sparton Announces Closing of First Tranche of Private Placement Offering of C$500,000 for its Critical Metals Exploration Programs and Inclusion of Finders’ Warrants for the Placement | TSXV:SRI | Sparton Resources Inc |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine | NASDAQ:REGN | Regeneron Pharmaceuticals Inc |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans | BIT:1SAN | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans | EU:SAN | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM | BIT:SANF | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM | BIT:1SAN | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine | NASDAQ:SNY | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans | BIT:SANF | Sanofi |
06/26/2024 | 5:30PM | GlobeNewswire Inc. | Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine | SAN.PA | |
06/26/2024 | 5:30PM | PR Newswire (Canada) | INTERRENT ESTABLISHES AUTOMATIC UNIT PURCHASE PLAN | TSX:IIP.UN | InterRent Real Estate Investment Trust |
06/26/2024 | 5:30PM | PR Newswire (Canada) | Mercer Park Opportunities Corp. Files Preliminary Prospectus for Initial Public Offering of Units | | |
06/26/2024 | 5:30PM | PR Newswire (US) | E-Passport Market size is set to grow by USD 18.96 billion from 2024-2028, Increasing security concerns to boost the market growth, Technavio | | |
06/26/2024 | 5:30PM | PR Newswire (Canada) | Greenlane Renewables Announces Results From 2024 Annual General Meeting of Shareholders | TSX:GRN | Greenlane Renewables Inc |
06/26/2024 | 5:30PM | PR Newswire (US) | Spacesuit Market size is set to grow by USD 231.1 million from 2024-2028, Implementation of 3D printing technologies boost the market, Technavio | | |
06/26/2024 | 5:28PM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | USOTC:BNSPF | Bank Nova Scotia Halifax (PK) |
06/26/2024 | 5:28PM | Business Wire | BODi by Beachbody Debuts Shakeology 0g Added Sugar Options | NYSE:BODI | Beachbody Company Inc |
06/26/2024 | 5:27PM | GlobeNewswire Inc. | Friedman Industries, Incorporated Announces Cash Dividend | AMEX:FRD | Friedman Industries Inc |
06/26/2024 | 5:27PM | Business Wire | 2024 ESSENCE Festival of Culture™ Ignites Culture & Conversation with Experiences featuring Serena Williams, Ava DuVernay, Big Freedia, Morris Chestnut, Regina Hall, Sanaa Lathan, Wayne Brady, Tiwa Savage, Marsai Martin, JT & More | | |
06/26/2024 | 5:26PM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJ | JP Morgan Alerian MLP |
06/26/2024 | 5:25PM | PR Newswire (US) | Marine Air Conditioning (AC) Systems Market size is set to grow by USD 3.70 billion from 2024-2028, Robust growth in commercial shipping to boost the market growth, Technavio | | |
06/26/2024 | 5:22PM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJ | JP Morgan Alerian MLP |